The relationship between various measures of obesity and arterial stiffness in morbidly obese patients

Table 2 Correlations between PWV, body composition, metabolic parameters and medications

Independent variables	Male (r)	Female (r)
Age	0.61†	0.52†
Hypertension‡	0.19	0.59†
Type 2 diabetes (yes/no)	0.46†	0.18
Visceral fat area (cm²)	-0.18	0.25*
Fat mass (kg)	-0.26	0.06
Fat free mass (kg)	-0.15	-0.04
apo-B/apoA-1 ratio	-0.29	0.10
Fasting insulin (mmol/L)	0.03	0.09
HOMA IR§	0.10	0.13
Fasting glucose (mmol/L)	0.35*	0.24*
HbA1c (%)	0.27	0.31*
β-blocker (yes/no)	0.12	0.39†
Calsium-channel blocker (yes/no)	0.36*	0.24*
Inhibitors of the RAA-system (yes/no)	0.29*	0.14
Statins (yes/no)	0.39*	0.22

*p < 0.05. †p < 0.001. ‡ Hypertension is defined by the patient receiving antihypertensive medication or having systolic bloodpressure ≥ 140 mmHg or diastoic blood pressure ≥ 90 mmHg. §Homeostasis Model Assessment Insulin Resistance

ISSN: 1471-2261